The Functional-765G→C Polymorphism of the COX-2 Gene May Reduce the Risk of Developing Crohn's Disease

被引:13
作者
de Vries, Hilbert S. [1 ]
Morsche, Rene H. M. Te [1 ]
van Oijen, Martijn G. H. [1 ,3 ]
Nagtegaal, Iris D. [2 ]
Peters, Wilbert H. M. [1 ]
de Jong, Dirk J. [1 ]
机构
[1] Radboud Univ Nijmegen, Dept Gastroenterol & Hepatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Dept Pathol, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[3] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands
关键词
INFLAMMATORY-BOWEL-DISEASE; CYCLOOXYGENASE; 2; MESSENGER-RNA; EXPRESSION; ASSOCIATION; COLITIS; CANCER; PREVALENCE; INHIBITORS; RELAPSE;
D O I
10.1371/journal.pone.0015011
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Cyclooxygenase-2 (COX-2) is a key enzyme involved in the conversion of arachidonic acid into prostaglandins. COX-2 is mainly induced at sites of inflammation in response to proinflammatory cytokines such as interleukin-1 alpha/beta, interferon-gamma and tumor necrosis factor-alpha produced by inflammatory cells. Aim: The aim of this study was to investigate the possible modulating effect of the functional COX-2 polymorphisms -1195 A -> G and -765G -> C on the risk for development of inflammatory bowel disease (IBD) in a Dutch population. Methods: Genomic DNA of 525 patients with Crohn's disease (CD), 211 patients with ulcerative colitis (UC) and 973 healthy controls was genotyped for the -1195 A -> G (rs689466) and -765G -> C (rs20417) polymorphisms. Distribution of genotypes in patients and controls were compared and genotype-phenotype interactions were investigated. Results: The genotype distribution of the -1195A -> G polymorphism was not different between the patients with CD or UC and the control group. The -765GC genotype was more prevalent in CD patients compared to controls with an OR of 1.33 (95% CI 1.04-1.69, p < 0.05). The -765GC and -765CC genotype carriers showed a tendency to be less frequent in patients with CD compared to controls, with ORs of 0.78 (95% CI: 0.61-1.00) and 0.49 (95% CI 0.22-1.08), respectively. Combining homozygous and heterozygous patients with the -765C allele showed a reduced risk for developing CD, with an OR of 0.75 (95% CI: 0.59-0.96). In the context of this, the G(-1195)G(-765)/A(-1195)C(-765) diplotype was significantly less common in patients with CD compared to controls, with an OR of 0.62 (95% CI: 0.39-0.98). For UC however, such an effect was not observed. No correlation was found between COX-2 diplotypes and clinical characteristics of IBD. Conclusions: The -765G -> C polymorphism was associated with a reduced risk for developing Crohn's disease in a Dutch population.
引用
收藏
页数:6
相关论文
共 40 条
[31]   Cyclooxygenase-2 expression and role of vasoconstrictor prostanoids in small mesenteric arteries from patients with Crohn's disease [J].
Tabernero, A ;
Reimund, JM ;
Chasserot, S ;
Muller, CD ;
Andriantsitohaina, R .
CIRCULATION, 2003, 107 (10) :1407-1410
[32]   Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease [J].
Takeuchi, K ;
Smale, S ;
Premchand, P ;
Maiden, L ;
Sherwood, R ;
Thjodleifsson, B ;
Bjornsson, E ;
Bjarnason, I .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (02) :196-202
[33]   Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer [J].
Tan, Wen ;
Wu, Jianxiong ;
Zhang, Xuemei ;
Guo, Yongli ;
Liu, Junniao ;
Sun, Tong ;
Zhang, Bailin ;
Zhao, Dan ;
Yang, Ming ;
Yu, Dianke ;
Lin, Dongxin .
CARCINOGENESIS, 2007, 28 (06) :1197-1201
[34]   Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis [J].
Trifan, OC ;
Hla, T .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2003, 7 (03) :207-222
[35]   COX-2: A pivotal enzyme in mucosal protection and resolution of inflammation [J].
Wallace, John L. .
THESCIENTIFICWORLDJOURNAL, 2006, 6 :577-588
[36]   Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic [J].
Warner, TD ;
Mitchell, JA .
FASEB JOURNAL, 2004, 18 (07) :790-804
[37]   Mechanisms of intestinal inflammation and development of associated cancers: Lessons learned from mouse models [J].
Westbrook, Aya M. ;
Szakmary, Akos ;
Schiestl, Robert H. .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2010, 705 (01) :40-59
[38]   Unravelling the pathogenesis of inflammatory bowel disease [J].
Xavier, R. J. ;
Podolsky, D. K. .
NATURE, 2007, 448 (7152) :427-434
[39]   Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer [J].
Zhang, XM ;
Miao, XP ;
Tan, W ;
Ning, BT ;
Liu, ZH ;
Hong, Y ;
Song, WG ;
Guo, YL ;
Zhang, XY ;
Shen, Y ;
Qiang, BQ ;
Kadlubar, FF ;
Lin, DX .
GASTROENTEROLOGY, 2005, 129 (02) :565-576
[40]   Interaction of Cyclooxygenase-2 Variants and Smoking in Pancreatic Cancer: A Possible Role of Nucleophosmin [J].
Zhao, Dan ;
Xu, Dongkui ;
Zhang, Xuemei ;
Wang, Li ;
Tan, Wen ;
Guo, Yongli ;
Yu, Dianke ;
Li, Hui ;
Zhao, Ping ;
Lin, Dongxin .
GASTROENTEROLOGY, 2009, 136 (05) :1659-1668